About CathVision
CathVision is a company based in Copenhagen (Denmark) founded in 2013 by Rune Orndrup.. CathVision has raised $36.08 million across 11 funding rounds from investors including European Union, EIC Fund and Danmarks Eksport- og Investeringsfond. The company has 21 employees as of November 30, 2024. CathVision offers products and services including ECGenius System and CARDIALYTICS. CathVision operates in a competitive market with competitors including AtriCure, AtaCor Medical, Kestra Medical Technologies, CardioFocus and Biosense Webster, among others.
- Headquarter Copenhagen, Denmark
- Employees 21 as on 30 Nov, 2024
- Founders Rune Orndrup
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cathvision Aps
-
Annual Revenue
-
Net Profit
$-1 M (USD)-38as on Dec 31, 2021
-
EBITDA
$-1.47 M (USD)-28as on Dec 31, 2021
-
Total Equity Funding
$36.08 M (USD)
in 11 rounds
-
Latest Funding Round
$9 M (USD), Series B
Jul 18, 2023
-
Investors
European Union
& 3 more
-
Employee Count
21
as on Nov 30, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CathVision
CathVision offers a comprehensive portfolio of products and services, including ECGenius System and CARDIALYTICS. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enhances cardiac electrical signals for improved arrhythmia diagnosis.
Offers automated tools for analyzing atrial fibrillation and other arrhythmias.
Unlock access to complete
Unlock access to complete
Funding Insights of CathVision
CathVision has successfully raised a total of $36.08M across 11 strategic funding rounds. The most recent funding activity was a Series B round of $9 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Series B — $9.0M
-
First Round
First Round
(24 Mar 2014)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2023 | Amount | Series B - CathVision | Valuation |
investors |
|
| May, 2022 | Amount | Series B - CathVision | Valuation |
investors |
|
| Jul, 2021 | Amount | Grant - CathVision | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CathVision
CathVision has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, EIC Fund and Danmarks Eksport- og Investeringsfond. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Provision of financing, loans, equity, and insurance for Danish export and investment activities.
|
Founded Year | Domain | Location | |
|
Borean is engaged in providing outdoor adventure experiences.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CathVision
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CathVision
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cathvision Comparisons
Competitors of CathVision
CathVision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AtriCure, AtaCor Medical, Kestra Medical Technologies, CardioFocus and Biosense Webster, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cardiac ablation and occlusion devices for atrial fibrillation are provided.
|
|
| domain | founded_year | HQ Location |
An implantable pacemaker system is developed for cardiac pacing therapy.
|
|
| domain | founded_year | HQ Location |
Medical devices are developed to support cardiovascular patients at risk.
|
|
| domain | founded_year | HQ Location |
Endoscopic catheter for atrial fibrillation ablation is developed.
|
|
| domain | founded_year | HQ Location |
Mapping catheters for cardiac arrhythmia treatment are developed.
|
|
| domain | founded_year | HQ Location |
Wireless cardiac pacing devices are developed for left ventricle stimulation.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cathvision
Frequently Asked Questions about CathVision
When was CathVision founded?
CathVision was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is CathVision located?
CathVision is headquartered in Copenhagen, Denmark.
Is CathVision a funded company?
CathVision is a funded company, having raised a total of $36.08M across 11 funding rounds to date. The company's 1st funding round was a Grant of $59.38K, raised on Mar 24, 2014.
How many employees does CathVision have?
As of Nov 30, 2024, the latest employee count at CathVision is 21.
What does CathVision do?
CathVision was founded in 2013 in Copenhagen, Denmark, as a developer of AI-based software and devices for cardiac electrophysiology in the medical technology sector. The CathVision Cube is provided to visualize electrophysiology signals, enabling accurate therapy delivery through low-noise ablation and high signal quality. Real-time streaming, analysis, and storage of EP signals are supported, with AI algorithms integrated into the interface for clinical decision support.
Who are the top competitors of CathVision?
CathVision's top competitors include AtaCor Medical, AtriCure and CardioFocus.
What products or services does CathVision offer?
CathVision offers ECGenius System and CARDIALYTICS.
Who are CathVision's investors?
CathVision has 4 investors. Key investors include European Union, EIC Fund, Danmarks Eksport- og Investeringsfond, and Borean.
What is CathVision's valuation?
The valuation of CathVision is $28.42M as of May 2022.